

1,402,022 filings since 2004 · latest accepted Nov 4, 2026, 7:13 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Oct 6, 2026 accepted 8:57 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Jun 3, 2026 accepted 9:41 PM ET | AURXNuo Therapeutics, Inc. |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
1.01Material agreement2.03New debt obligation3.02Unregistered equity sale |
| DocumentSEC ↗ |
Jan 26, 2026 accepted 9:25 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Dec 12, 2019 accepted 2:00 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Nov 20, 2019 accepted 9:30 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Sep 21, 2018 accepted 8:33 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Jul 1, 2014 accepted 8:46 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Dec 3, 2013 accepted 9:18 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Nov 22, 2013 accepted 2:55 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Feb 20, 2013 accepted 1:22 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.02Earnings release2.03New debt obligation3.02Unregistered equity sale3.03Holder rights modified8.01Other events | DocumentSEC ↗ |
Nov 25, 2011 accepted 7:40 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Jul 20, 2011 accepted 8:29 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale7.01Reg FD disclosure | DocumentSEC ↗ |
May 3, 2011 accepted 4:57 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale7.01Reg FD disclosure | DocumentSEC ↗ |
Apr 12, 2010 accepted 8:26 PM ET | AURXNuo Therapeutics, Inc. | 1.01Material agreement2.01Acquisition / disposition2.03New debt obligation3.02Unregistered equity sale5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |